News & Press Releases

Bloomberg Law quoted Joanne Hawana in a recent article about the FDA’s crackdown on potentially misleading drug advertisements following its investigation into the use of social media influencers to promote certain drugs. Attorneys and the telehealth companies they counsel explain in the article that clarity from the FDA is needed on who is responsible for influencer ad messaging, particularly when promoting compounded drugs.

Member Tara Dwyer was recently quoted in Law360 Healthcare Authority regarding a federal ruling that could impact how the Centers for Medicare & Medicaid Services (CMS) conducts audits of Medicare Advantage plans. The ruling limits CMS from using small sample sizes to represent entire patient populations, which may challenge its goal of performing 550 audits annually to curb fraud and overbilling.

Member Daniel Cody shared insights with Part B News about the federal government shutdown and its potential impact on Medicare providers. The Centers for Medicare & Medicaid Services (CMS) has issued little guidance for providers related to the implications of the shutdown.

Jacob Hupart shared insights with Responsible Investor about the final ruling in a suit against American Airlines over its investment of 401(k) money with asset managers pursuing ESG goals. The judge ruled that the airline had broken its “duty of loyalty” but rejected claims for damages.

Boston Business Journal connected with John Rudy to discuss private investment in public equity (PIPE) financings for an article that outlines their purpose, what entering a PIPE could signify for companies, and how they might be particularly useful for SPAC mergers.

Fiduciary News quoted Of Counsel Michelle Capezza in an article about the rise of AI advice tools in retirement plan platforms. While these tools may offer efficient, data-driven, and personalized advice, they also present risks such as data breaches, opaque algorithms, and biased results.